SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-18-033895
Filing Date
2018-07-27
Accepted
2018-07-27 16:28:22
Documents
4
Period of Report
2018-07-27
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K s002128x30_8k.htm 8-K 24339
2 EXHIBIT 3.1 s002128x30_ex3-1.htm EX-3.1 35461
3 EXHIBIT 99.1 s002128x30_ex99-1.htm EX-99.1 7248
4 s002128x30ex99-1_image01.jpg GRAPHIC 2164
  Complete submission text file 0001140361-18-033895.txt   71420
Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address 30 TECHNOLOGY DRIVE WARREN NJ 07059 908-941-1900
Aquestive Therapeutics, Inc. (Filer) CIK: 0001398733 (see all company filings)

IRS No.: 208623253 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38599 | Film No.: 18975106
SIC: 2834 Pharmaceutical Preparations